Axel Mark Inc.
Notice Regarding Termination of Commitment-Type Term Loan Facility with Parent Company
Terminated the commitment-type term loan facility with parent company Convano. The reason is continued risk of losses and a major shift in financial strategy, switching to equity-based fundraising. Large M&A in the healthcare sector is currently put on hold. Going forward, the company will consider equity-centered financing.
Key Figures
- Maximum Borrowing Limit: 30 hundred million yen
- Paid-in Amount for Third-Party Allotment: 9 hundred million yen
- Interest Rate: Annual rate 2.0% (fixed)
AI要約
Summary of the News
Following financing on May 29, 2026, Axel Mark Inc. faced a series of unforeseen events and substantially changed its financial strategy. The company terminated the commitment-type term loan facility agreement with parent company Convano (maximum borrowing limit of 30 hundred million yen) and formally decided and agreed to shift fundraising methods to be equity-centered. As a result of this termination, large-scale M&A in the healthcare sector will be put on hold for the time being, and cash and interest-bearing debt balances remain unchanged.
Future Fundraising and Impact
With the termination of this facility agreement, the company will steer its capital policy to prioritize equity financing. The company will continue to consider healthcare M&A within the scope of the paid-in amount from the third-party allotment, but large deals are expected to be difficult at present. Working capital will rely on capital that does not require repayment. This decision is considered a rational judgment prioritizing maintenance of financial soundness and protection of minority shareholders.
Axel Mark Inc.
Company overview · Stock price · Financial data · All IR
